Dear Researchers,

The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Nemes Zoltán

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

1975-2017

2017

Rentka, A., Grygar, J., Nemes, Z., Kemény-Beke, Á.: Evaluation of carbon dioxide laser therapy for benign tumors of the eyelid margin.
Lasers Med. Sci. 32 (8), 1901-1907, 2017.

doi DEA

Journal metrics:

Q2 Dermatology

Q2 Surgery

2012

Tsakiris, I., Töröcsik, D., Gyöngyösi, A., Dózsa, A., Szatmári, I., Szántó, A., Soós, G., Nemes, Z., Igali, L., Márton, I., Takáts, Z., Nagy, L., Dezső, B.: Carboxypeptidase-M is regulated by lipids and CSFs in macrophages and dendritic cells and expressed selectively in tissue granulomas and foam cells.
Lab. Invest. 92 (3), 345-361, 2012.

doi DEA WoS Scopus

Journal metrics:

Q2 Cell Biology

Q2 Molecular Biology

D1 Pathology and Forensic Medicine

2011

Tóth, M., Szűcs, N., Jakab, Z., Doros, A., Rácz, K., Nemes, Z.: Malignus Insulinoma.
Orv. Hetil. 152 (10), 398-402, 2011.

doi DEA

Journal metrics:

Q3 Medicine (miscellaneous)

2010

Francz, M., Egervári, K., Kardos, L., Tóth, J., Nemes, Z., Szántó, J., Szöllősi, Z.: Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study.
J. Clin. Pathol. 63 (4), 341-346, 2010.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Pathology and Forensic Medicine

Tóth, L., Nemes, Z., Gomba, S., Asztalos, L., Molnár, C., András, C., Szentirmay, Z., Molnár, P. P.: Primary rhabdoid cancer of the ileum: a case report and review of the literature.
Pathol. Res. Pract. 206 (2), 110-115, 2010.

doi DEA

Journal metrics:

Q4 Cell Biology

Q2 Pathology and Forensic Medicine

Kemény-Beke, Á., Barta, Z., Tóth, L., Nemes, Z., Gesztelyi, R., Módis, L., Facskó, A., Berta, A., Szodoray, P.: Total nasolacrimal duct obstruction in 2 patients with inflammatory bowel disease.
Inflamm. Bowel Dis. 16 (10), 1637-1639, 2010.

doi DEA

Journal metrics:

D1 Gastroenterology

Q1 Immunology and Allergy

2009

Tóth, J., Egervári, K., Klekner, Á., Bognár, L., Szántó, J., Nemes, Z., Szöllősi, Z.: Analysis of EGFR gene amplification, protein over-expression and tyrosine kinase domain mutation in recurrent glioblastoma.
Pathol. Oncol. Res. 15 (2), 225-229, 2009.

doi DEA

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q2 Oncology

Q2 Pathology and Forensic Medicine

Váncsa, A., Gergely, L., Nemes, Z., Biró, E., Illés, Á., Bakó, G.: Pseudolymphoma orvitae.
Magyar Immunol. 7, 37-41, 2009.

DEA

2008

Pethő, Z., Szabó, Z., Brugós, L., Nemes, Z., Szöllősi, Z., Sándor, Z., Pápay, Z., Szekanecz, Z.: Mellkasi lágyrésztumor: rheumatoid csomó? : esetismertetés.
Magyar Reumatol. 49, 172, 2008.

DEA

10.

Tsakiris, I., Soós, G., Nemes, Z., Kiss, S. S., András, C., Szántó, J., Dezső, B.: The presence of carboxypeptidase-M in tumour cells signifies epidermal growth factor receptor expression in lung adenocarcinomas: the coexistence predicts a poor prognosis regardless of EGFR levels.
J. Cancer Res. Clin. Oncol. 134 (4), 439-451, 2008.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Medicine (miscellaneous)

Q2 Oncology

2007

11.

Ress, Z., Illés, Á., Tanyi, M., Nemes, Z., Weisz, G., Kovács, I., Váróczy, L., Gergely, L.: Primary splenic diffuse large B-cell non-Hodgkin's lymphoma and hepatitis C virus infection.
Hematol. Transzfuziol. 40 (3), 236-240, 2007.

DEA

12.

Keresztes, K., Szöllősi, Z., Simon, Z., Tárkányi, I., Nemes, Z., Illés, Á.: Retrospective analysis of the prognostic role of tissue eosinophil and mast cells in Hodgkin's lymphoma.
Pathol. Oncol. Res. 13 (3), 237-242, 2007.

doi DEA

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q2 Oncology

Q2 Pathology and Forensic Medicine

13.

Egervári, K., Szöllősi, Z., Nemes, Z.: Tissue microarray technology in breast cancer HER2 diagnostics.
Pathol. Oncol. Res. 203 (3), 169-177, 2007.

doi DEA

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q2 Oncology

Q2 Pathology and Forensic Medicine

14.

Szöllősi, Z., Scholtz, B., Egervári, K., Nemes, Z.: Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.
J. Clin. Pathol. 60 (2), 190-194, 2007.

doi DEA

Journal metrics:

D1 Medicine (miscellaneous)

Q1 Pathology and Forensic Medicine

2006

15.

Keresztes, K., Miltényi, Z., Bessenyei, B., Beck, Z., Szöllősi, Z., Nemes, Z., Oláh, É., Illés, Á.: Association between the Epstein-Barr virus and Hodgkin's lymphoma in the Nort-Eastern part of Hungary: effect on therapy and survival.
Acta Haematol. 116 (2), 101-107, 2006.

doi

Journal metrics:

Q3 Hematology

Q2 Medicine (miscellaneous)

16.

Palatka, K., Serfőző, Z., Veréb, Z., Bátori, R. K., Lontay, B., Hargitay, Z., Nemes, Z., Udvardy, M., Erdődi, F., Altorjay, I.: Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells.
World J. Gastroenterol. 12 (11), 1730-1738, 2006.

doi DEA

Journal metrics:

Q2 Gastroenterology

Q2 Medicine (miscellaneous)

17.

Keresztes, K., Simon, Z., Szöllősi, Z., Nemes, Z., Tárkányi, I., Illés, Á.: Eosinophil és hízósejtek prognosztikai jelentőségének retrospektív vizsgálata Hodgkin-lymphomás betegek szövettani mintáiban.
Hematol. Transzfuziol. 39 (2), 56-62, 2006.

DEA

18.

Nemes, J., Deli, L., Nemes, Z., Márton, I.: Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 102 (3), 344-352, 2006.

doi DEA

19.

Szilasi, M., Dolinay, T., Nemes, Z., Strausz, J.: Pathology of chronic obstructive pulmonary disease.
Pathol. Oncol. Res. 12 (1), 52-60, 2006.

doi DEA

Journal metrics:

Q3 Cancer Research

Q2 Medicine (miscellaneous)

Q2 Oncology

Q2 Pathology and Forensic Medicine

20.

Egervári, K., Szöllősi, Z., Nemes, Z.: Reply to IHC for HER2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma.
J. Clin. Pathol. 59, 2006.

DEA

2005

21.

Palatka, K., Serfőző, Z., Veréb, Z., Hargitay, Z., Lontay, B., Erdődi, F., Bánfalvi, G., Nemes, Z., Udvardy, M., Altorjay, I.: Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
Scand. J. Gastroenterol. 40 (6), 670-680, 2005.

doi DEA

Journal metrics:

Q1 Gastroenterology

22.

Keresztes, K., Miltényi, Z., Bessenyei, B., Beck, Z., Szöllősi, Z., Nemes, Z., Oláh, É., Illés, Á.: Effect of Epstein-Barr virus association on therapeutic and survival results in Hodgkin's lymphoma in Hungary (528).
Ann. Oncol. 16, v191-v192, 2005.

DEA

23.

Illés, Á., Bessenyei, B., Szöllősi, Z., Beck, Z., Miltényi, Z., Nemes, Z., Oláh, É., Keresztes, K.: Epstein-Barr virus association in Hodgkin's lymphoma in Hungary (345).
Ann. Oncol. 16, 2005.

DEA

24.

Keresztes, K., Bessenyei, B., Szöllősi, Z., Beck, Z., Miltényi, Z., Nemes, Z., Oláh, É., Illés, Á.: Epstein-Barr-vírus-asszociáció Hodgkin-lymphomában, hatása a kezelési és túlélési eredményekre.
Hematológia-transzfuziológia. 38 (2), 65-75, 2005.

25.

Szöllősi, Z., Németh, T., Egervári, K., Nemes, Z.: Histiocyte-like cells expressing factor XIIIa do not belong to the neoplastic cell population in malignant fibrous histiocytoma.
Pathol. Res. Pract. 201 (5), 369-377, 2005.

doi DEA

Journal metrics:

Q4 Cell Biology

Q2 Pathology and Forensic Medicine